Blood Pressure Lowering Effects of a Novel Long-Acting NPR1 Agonist, XXB750, in Healthy Participants: A Randomized, First-in-Human Clinical Study
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1161/circulationaha.124.072636
文献链接: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.124.072636
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: YanLing He; Xueping Wu; Andre Serra-Roma; Maggie Markiewicz; Emma Healy; Jing-He Yan; Kenneth Kulmatycki; Tong Zhang; John L. Diener; Arvind G. Kinhikar; Denise P. Yates; David Nguyen; Markus Hinder; Cesare Russo; Christopher J. O’Donnell